Header graphic for print
Dangerous Drugs & Medical Devices News & Commentary on Prescription Drug & Medical Device Lawsuits

Category Archives: SSRI Birth Defects

Subscribe to SSRI Birth Defects RSS Feed

2005 – Late exposure to SSRIs in pregnancy risks negative consequences

Posted in SSRI Birth Defects

Titled “Treatment with selective serotonin reuptake inhibitors in the third trimester of pregnancy: effects on the infant.”, a 2005 Drug Safety article by H. Nordeng and a team from The University of Oslo (Norway) explores the effects of late pregnancy exposure to selective serotonin reuptake inhibitor drugs (SSRIs).  In the past two decades, droves of… Continue Reading

Study links SSRI exposure with smaller head circumference

Posted in SSRI Birth Defects

In March, 2012, G. Dubnov-Raz and a team of Israeli researchers published an article in Early Human Development titled “Maternal use of selective serotonin reuptake inhibitors during pregnancy and neonatal bone density.” that explores negative consequences of prenatal exposure to selective serotonin reuptake inhibitor drugs (SSRIs).  To-date, scores of peer-reviewed scientific studies have demonstrated that… Continue Reading

2013 – Developmental, social problems in children with prenatal SSRI exposure

Posted in SSRI Birth Defects

A Psychopharmacology article published last summer by T.L Gur and a team from the Perelman School of Medicine (University of Pennsylvania) titled “Central nervous system effects of prenatal selective serotonin reuptake inhibitors: sensing the signal through the noise.” reviews the consequences on the central nervous system (CNS) of prenatal exposure to selective serotonin reuptake inhibitor… Continue Reading

2012 – Babies exposed to SSRIs found 80% more likely to die before one year

Posted in SSRI Birth Defects

An article titled “Early morbidity and mortality following in utero exposure to selective serotonin reuptake inhibitors: a population-based study in Western Australia.” by L. Colvin et al. (2012) first published in that year’s July edition of CNS Drugs explores the link between gestational exposure to SSRI drugs and adverse birth outcomes.  To be clear, SSRIs… Continue Reading

2007 – Risks of SSRIs in pregnancy explored

Posted in SSRI Birth Defects

In December, 2007, a study titled “[Use of SSRIs during pregnancy and possible consequences for the development of the child].” published in Nederlands tijdschrift voor geneeskunde (or, “Dutch Journal of Medicine”) by C.N. van der Veere et al discusses poor neonatal outcomes linked to SSRI use in pregnancy. The authors of this short piece state… Continue Reading

2014 – Harvard Medical School: SSRIs dramatically increase risk for preterm birth and low birth weight

Posted in SSRI Birth Defects

Today, I came across a 2014 article by H. Huang et al. from Harvard Medical School titled “A meta-analysis of the relationship between antidepressant use in pregnancy and the risk of preterm birth and low birth weight.” published in General Hospital Psychiatry that examined the relationship between gestational exposure to selective serotonin reuptake inhibitor drugs… Continue Reading

2013 – SSRIs raise risk for poor neonatal adaptation by 96%

Posted in SSRI Birth Defects

Looking through PubMed Health, a medical research database curated by the United States National Library of Medicine and The National Institutes of Health, I recently found an article from The British Journal of Psychiatry by H.M. Jensen titled “Maternal depression, antidepressant use in pregnancy and Apgar scores in infants.”.  This team of Danish medical researchers… Continue Reading

2007 – SSRI exposure “may interfere with the physiology of the respiratory system” in developing babies

Posted in SSRI Birth Defects

A 2007 article titled “Serotonin reuptake inhibitor-induced perinatal complications.” by S. Gentil and a team of researchers from Italy published in Paediatric Drugs delves further into the risks of SSRI use during pregnancy.  To be clear, selective serotonin reuptake inhibitors (SSRIs) are psychiatric medications like Paxil, Prozac, Zoloft, and others – some of the world’s… Continue Reading

2008 – Poor neonatal outcomes linked to SSRI exposure

Posted in SSRI Birth Defects

In June 2008, N. Boucher and a team of researchers from Laval University (Quebec) published the results of a study titled “A new look at the neonate’s clinical presentation after in utero exposure to antidepressants in late pregnancy.” in the ever-prominent Journal of Clinical Psychopharmacology, providing further insight into the risks of SSRI use in… Continue Reading

2012 – Some babies exposed to SSRIs five times as likely to have infant convulsions

Posted in SSRI Birth Defects

In July 2012, the medical journal American Journal of Obstetrics and Gynecology published a study by R.M. Hayes et al. titled “Maternal antidepressant use and adverse outcomes: a cohort study of 228,876 pregnancies.”.  This study, from Vanderbilt University (Nashville), provides important insight into the risks associated with SSRI use in pregnancy.  To-date, these psychiatric drugs… Continue Reading

2010 – Depression and Anxiety: SSRIs linked to increased premature birth rate

Posted in SSRI Birth Defects

In 2010, a team of prominent SSRI birth defects researchers led by A. Einarson (Toronto) published a study in Depression and Anxiety titled “Adverse effects of antidepressant use in pregnancy: an evaluation of fetal growth and preterm birth.”  Here, the team’s stated objective was “To compare the rates of low birth weight, preterm delivery and… Continue Reading

2007 – Medication, not maternal depression, linked to poor neonatal outcomes

Posted in SSRI Birth Defects

In 2007, a team of medical researchers from UCLA published a study titled “Effects of antenatal depression and antidepressant treatment on gestational age at birth and risk of preterm birth.” in The American Journal of Psychiatry that “evaluated the effects of prenatal antidepressant exposure and maternal depression on infant gestational age at birth and risk… Continue Reading

2012 – Range of poor neonatal outcomes linked to SSRIs in pregnancy

Posted in Prozac Birth Defects, SSRI Birth Defects, Zoloft Birth Defects

Over the past several decades, drugs like Prozac and Zoloft have come under fire over a connection to birth defects (and host of other negative consequences related to SSRI use in pregnancy).  Recently, I came across a piece by L.E. Grzeskowiak et al. (2012) published in Journal of Clinical Psychopharmacology titled “Neonatal outcomes after late-gestation… Continue Reading

2008 – Serious birth defects linked to prenatal SSRI exposure

Posted in SSRI Birth Defects

A 2008 article appearing in the August edition of Prescrire International titled “SSRI antidepressants and persistent pulmonary hypertension in newborns.” further examines the adverse effects of exposure to selective serotonin reuptake inhibitor drugs (SSRIs) during pregnancy.  In recent decades, a number of prominent studies have linked heart defects to SSRIs, but many other negative consequences… Continue Reading

2013 – Children born to mothers who used SSRIs 19% more likely small for gestational age

Posted in SSRI Birth Defects

Published in the July, 2013 edition of Psychopharmacology by a team of Danish researchers led by H.M. Jensen, an article titled “The effects of maternal depression and use of antidepressants during pregnancy on risk of a child small for gestational age.” attempts to sort out whether maternal depression or maternal medication leads to children being… Continue Reading

2009 – Researcher find SSRI exposure linked to premature birth

Posted in SSRI Birth Defects

An article by K.L. Wisner et al. published in the May, 2009 edition of American Journal of Psychiatry titled “Major depression and antidepressant treatment: impact on pregnancy and neonatal outcomes.” provides important insight into the adverse effects of SSRI use during pregnancy.  This piece comes from Women’s Behavioral HealthCARE and the Department of Psychiatry at… Continue Reading

2009 – Paxil, SSRIs linked to serious birth defects and poor early adaptation

Posted in Paxil Birth Defects, SSRI Birth Defects

Looking through articles today at PubMed Health, a service of the United States National Library of Medicine and The National Institutes of Health, I found a piece titled “The management of depression during pregnancy: a report from the American Psychiatric Association and the American College of Obstetricians and Gynecologists.” published by K.A. Yonkers et al…. Continue Reading

2008 – Breathing problems linked to prenatal SSRI exposure

Posted in SSRI Birth Defects

In May, 2008, a team of medical researchers led by T.F. Oberlander published an article titled “Effects of timing and duration of gestational exposure to serotonin reuptake inhibitor antidepressants: population-based study.” in British Journal of Psychiatry that provides more insight into the link between adverse birth outcomes and prenatal exposure to selective serotonin reuptake inhibitor… Continue Reading

2011 – Study shows SSRIs in pregnancy linked to poor neonatal adaptation

Posted in SSRI Birth Defects

Today, I found a 2011 article in Psychopharmacology by R.C. Casper titled “Length of prenatal exposure to selective serotonin reuptake inhibitor (SSRI) antidepressants: effects on neonatal adaptation and psychomotor development.” that further illustrates how SSRI use during pregnancy can lead to poor neonatal development and adverse birth outcomes. This article, from The Department of Psychiatry… Continue Reading

2006 – Huge study shows problems from antidepressants in pregnancy

Posted in SSRI Birth Defects

In August 2006, a team of Canadian researchers led by TF Oberlander published a study in Archives of General Psychiatry titled “Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data.” exploring the connection between prenatal exposure to selective serotonin reuptake inhibitor drugs (SSRIs) and adverse… Continue Reading

2013 – Meta-analysis study links SSRIs and poor neonatal outcomes

Posted in SSRI Birth Defects

In April 2013, a team of medical researchers from The Centre for Addiction and Mental Health at The University of Toronto published a study titled “Selected pregnancy and delivery outcomes after exposure to antidepressant medication: a systematic review and meta-analysis.” in JAMA Psychiatry.  This research team, led by L.E. Ross, studied the connection between gestational… Continue Reading

2010 – More research links SSRI exposure and poor birth outcomes

Posted in SSRI Birth Defects

In 2010, a team of researchers from Deakin University in Melbourne (Australia) led by A.J. Lewis published a study titled “Neonatal growth outcomes at birth and one month postpartum following in utero exposure to antidepressant medication.” in The Australian and New Zealand Journal of Psychiatry that aimed to clear up concerns of adverse neonatal outcomes… Continue Reading

2008 – Genetic dimension of SSRI-birth defects explored

Posted in SSRI Birth Defects

Titled “Infant serotonin transporter (SLC6A4) promoter genotype is associated with adverse neonatal outcomes after prenatal exposure to serotonin reuptake inhibitor medications.”, a paper by T.F. Oberlander et al. (2008) appearing in Molecular Psychiatry, examines a genetic dimension of the adverse effects of prenatal exposure to selective serotonin reuptake inhibitor drugs (SSRIs).  This team from The… Continue Reading

2006 – Remeron use in pregnancy lifts risk for spontaneous abortion

Posted in SSRI Birth Defects

In August 2006, an article titled “Exposure to mirtazapine during pregnancy: a prospective, comparative study of birth outcomes.” was published by J. Djulus et al. in Journal of Clinical Psychiatry concerning the safety of the antidepressant Remeron (mirtazapine) for a developing fetus.  To-date, a number of other studies have examined the risks of antidepressants during… Continue Reading